Scarica l'app Stockscreener
1.48
1.37%
0.02
Dopo l'orario di chiusura:
1.48
Precedente Chiudi:
$1.46
Aprire:
$1.5
Volume 24 ore:
75,229
Relative Volume:
0.13
Capitalizzazione di mercato:
$6.07M
Reddito:
$502.40K
Utile/perdita netta:
$-7.91M
Rapporto P/E:
-0.1484
EPS:
-9.972
Flusso di cassa netto:
$-4.32M
1 W Prestazione:
+13.85%
1M Prestazione:
+10.45%
6M Prestazione:
-6.92%
1 anno Prestazione:
-78.39%
Intervallo 1D:
$1.42
$1.50
Intervallo di 1 settimana:
$1.27
$1.5199
Portata 52W:
$1.215
$12.45
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Nome
60 Degrees Pharmaceuticals Inc
Settore
Industria
Telefono
202-327-5422
Indirizzo
1025 CONNECTICUT AVENUE NW, WASHINGTON
Confronta SXTP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.48 | 5.83M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie
How to escape a deep drawdown in 60 Degrees Pharmaceuticals Inc.Trade Entry Summary & Entry Point Strategy Guides - Newser
How institutional ownership impacts 60 Degrees Pharmaceuticals Inc. Equity Warrant stockInflation Watch & Fast Entry Momentum Alerts - Newser
Using data tools to time your 60 Degrees Pharmaceuticals Inc. Equity Warrant exitQuarterly Profit Review & Fast Exit and Entry Strategy Plans - Newser
Intraday pattern recognizer results for 60 Degrees Pharmaceuticals Inc. Equity WarrantTrade Analysis Summary & Scalable Portfolio Growth Ideas - Newser
Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
60 Degrees Pharma updates conference presentation webcast link, rescheduled for September 9. - AInvest
60 Degrees Pharmaceuticals Presents at H.C. Wainwright 27th Annual Global Investment Conference on September 9 - AInvest
Vector-borne Disease Biotech 60 Degrees Pharmaceuticals Sets New Time for H.C. Wainwright Conference - Stock Titan
Can volume confirm reversal in 60 Degrees Pharmaceuticals Inc. Equity WarrantWeekly Gains Summary & Technical Analysis for Trade Confirmation - Newser
Custom watchlist performance reports with 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Market Outlook & Weekly Top Gainers Alerts - Newser
How to build a custom watchlist for 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Big Picture & Risk Managed Investment Entry Signals - Newser
Using data tools to time your 60 Degrees Pharmaceuticals Inc. exitTrade Analysis Report & Real-Time Volume Surge Alerts - Newser
Regression analysis insights on 60 Degrees Pharmaceuticals Inc. performanceLayoff News & Daily Volume Surge Trade Alerts - Newser
Is 60 Degrees Pharmaceuticals Inc. meeting your algorithmic filter criteriaTrade Risk Summary & Weekly Top Gainers Trade List - Newser
Forecasting 60 Degrees Pharmaceuticals Inc. price range with options dataJuly 2025 Weekly Recap & Community Consensus Stock Picks - Newser
Does 60 Degrees Pharmaceuticals Inc. Equity Warrant fit your quant trading modelEarnings Risk Report & High Yield Stock Recommendations - Newser
Can 60 Degrees Pharmaceuticals Inc. maintain sales growthJuly 2025 Spike Watch & Smart Allocation Stock Reports - khodrobank.com
What’s the outlook for 60 Degrees Pharmaceuticals Inc. Equity Warrant’s sectorTrade Analysis Report & Low Volatility Stock Recommendations - khodrobank.com
Applying chart zones and confluence areas to 60 Degrees Pharmaceuticals Inc.2025 Support & Resistance & Daily Risk Controlled Trade Plans - Newser
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock ready for a breakoutQuarterly Profit Summary & Weekly Top Performers Watchlists - Newser
What institutional flow reveals about 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - Newser
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from government policy2025 Analyst Calls & Technical Pattern Based Signals - khodrobank.com
Is 60 Degrees Pharmaceuticals Inc. a cyclical or defensive stock2025 Technical Overview & Expert Approved Momentum Ideas - khodrobank.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from rising consumer demandJuly 2025 Breakouts & Verified Momentum Watchlists - khodrobank.com
Does 60 Degrees Pharmaceuticals Inc. Equity Warrant offer margin of safetyQuarterly Risk Review & Technical Analysis for Trade Confirmation - khodrobank.com
Building trade automation scripts for 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Combining price and volume data for 60 Degrees Pharmaceuticals Inc.July 2025 Reactions & Free Reliable Trade Execution Plans - Newser
Multi asset correlation models including 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Biggest Moves & Fast Moving Market Watchlists - Newser
Is 60 Degrees Pharmaceuticals Inc. forming a double bottomTrade Risk Summary & Technical Pattern Recognition Alerts - khodrobank.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock undervalued right now2025 Trading Volume Trends & Weekly Stock Performance Updates - khodrobank.com
Will 60 Degrees Pharmaceuticals Inc. benefit from rate cutsMarket Weekly Review & Weekly Chart Analysis and Guides - khodrobank.com
Visual analytics tools that track 60 Degrees Pharmaceuticals Inc. Equity Warrant performance2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Sentiment analysis tools applied to 60 Degrees Pharmaceuticals Inc. Equity WarrantShare Buyback & Growth Focused Stock Reports - Newser
What are 60 Degrees Pharmaceuticals Inc.’s earnings expectations2025 Growth vs Value & AI Powered Market Entry Ideas - khodrobank.com
Can 60 Degrees Pharmaceuticals Inc. be recession proofExit Point & Technical Pattern Alert System - khodrobank.com
Can a trend reversal in 60 Degrees Pharmaceuticals Inc. lead to recovery2025 AllTime Highs & Daily Profit Focused Screening - Newser
Market reaction to 60 Degrees Pharmaceuticals Inc. Equity Warrant’s recent newsQuarterly Earnings Summary & Detailed Earnings Play Strategies - Newser
Heatmap analysis for 60 Degrees Pharmaceuticals Inc. Equity Warrant and competitorsJuly 2025 Update & AI Driven Price Predictions - Newser
Intraday pattern recognizer results for 60 Degrees Pharmaceuticals Inc.Weekly Trade Recap & Weekly Hot Stock Watchlists - Newser
What technical models suggest about 60 Degrees Pharmaceuticals Inc.’s comebackWeekly Gains Report & Reliable Volume Spike Trade Alerts - Newser
Has 60 Degrees Pharmaceuticals Inc. Equity Warrant found a price floorStock Surge & Weekly High Return Stock Opportunities - Newser
Does 60 Degrees Pharmaceuticals Inc. qualify in momentum factor screeningMarket Sentiment Report & AI Forecast for Swing Trade Picks - Newser
60 Degrees Pharmaceuticals Inc. Equity Warrant’s volatility index tracking explainedEarnings Miss & Breakout Confirmation Alerts - Newser
Tools to assess 60 Degrees Pharmaceuticals Inc.’s risk profileInflation Watch & Reliable Intraday Trade Plans - Newser
Does 60 Degrees Pharmaceuticals Inc. fit your quant trading modelWeekly Stock Analysis & Weekly Setup with High ROI Potential - Newser
What the charts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant todayJuly 2025 Update & Consistent Return Strategy Ideas - Newser
60 Degrees Pharmaceuticals Inc Azioni (SXTP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
60 Degrees Pharmaceuticals Inc Azioni (SXTP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):